Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Current Assets (2016 - 2025)

Historic Current Assets for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to $9.6 million.

  • Traws Pharma's Current Assets rose 786.73% to $9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year increase of 786.73%. This contributed to the annual value of $25.0 million for FY2024, which is 1011.03% up from last year.
  • Traws Pharma's Current Assets amounted to $9.6 million in Q3 2025, which was up 786.73% from $15.4 million recorded in Q2 2025.
  • In the past 5 years, Traws Pharma's Current Assets ranged from a high of $59.9 million in Q3 2021 and a low of $8.9 million during Q3 2024
  • Over the past 5 years, Traws Pharma's median Current Assets value was $30.4 million (recorded in 2023), while the average stood at $32.7 million.
  • As far as peak fluctuations go, Traws Pharma's Current Assets soared by 18017.59% in 2021, and later tumbled by 6696.53% in 2024.
  • Quarter analysis of 5 years shows Traws Pharma's Current Assets stood at $55.4 million in 2021, then decreased by 29.01% to $39.3 million in 2022, then tumbled by 42.41% to $22.7 million in 2023, then increased by 10.11% to $25.0 million in 2024, then tumbled by 61.42% to $9.6 million in 2025.
  • Its last three reported values are $9.6 million in Q3 2025, $15.4 million for Q2 2025, and $18.9 million during Q1 2025.